Intranasal creatine prodrug shows early brain activity in phase 1 trial
A phase 1 trial found that intranasal creatine prodrug CBT101 was tolerated and produced exploratory EEG changes consistent with central ...
Tag: CBT101
POPULAR NEWS
-
Intranasal creatine prodrug shows early brain activity in phase 1 trial
-
Genome Study Maps Polygenic Coastal Adaptation in Song Sparrows
-
Thicker titanium gyroids show stronger static response without direct porosity–fatigue link
-
Pediatric suspected myocarditis linked to 40% mortality in Pakistan cohort